Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Regeneron Pharmaceuticals, Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $91.1 Billion
- Q4 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 10,562 shares of REGN stock, worth $7.53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,562
Previous 41,331
74.45%
Holding current value
$7.53 Million
Previous $43.4 Million
82.69%
% of portfolio
0.01%
Previous 0.05%
Shares
33 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.62 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.02 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.04 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.45 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.38 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...